How a CDMO Accelerates Biopharma Development from Lab to Market
Bringing a new biopharmaceutical product to market is one of the most complex undertakings in modern industry. It takes years of development, hundreds of millions of dollars of investment, myriad regulatory hurdles, and a manufacturing capability that most drug developers do not possess to take a new molecular entity discovered in the lab and make …